Trial Profile
Effects of Thiazolidinediones on Human Bone Marrow Stromal Cell Differentiation Capacity:In Vitro and In Vivo- A Pilot Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 06 Jun 2012 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 06 Jun 2012 Actual patient number is 10 according to ClinicalTrials.gov.
- 06 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.